The future of biomedical innovation depends in part on a new trend for all players in biomedical innovation to work together for the common goal, say 2 MIT researchers
It’s a long, expensive, risky road to turn a scientific breakthrough into a treatment that can help patients. Fewer organizations are trying to tackle the challenges alone, says a new paper from MIT researchers published August 28 in the journal Science Translational Medicine.
An essential new way to move discoveries forward has emerged in the form of multi-stakeholder collaborations involving three or more different types of organizations, such as drug companies, government regulators and patient groups, write Magdalini Papadaki, a research associate, and Gigi Hirsch, a physician-entrepreneur and executive director of the MIT Center for Biomedical Innovation.
The authors are calling for a new “science of collaboration” to learn what works and doesn’t work; to improve how leaders can design, manage and evaluate collaborations; and to help educate and train future leaders with the necessary organizational and managerial skills.
“Getting new, better, affordable drugs to the right patients faster involves a series of historically independent decisions made by different players or stakeholders,” says Hirsch. The system is uncoordinated, takes too long, and costs too much. In some cases, the drug—such as new antibiotics for life-threatening resistant infections—may never become available.
“One of the interesting paradoxes of biomedical innovation is increasingly going to be that even though we have the scientific knowledge required to provide potentially better treatments for patients—or even to prevent disease in those who are at high risk—we may be unable to help patients benefit from them anytime soon,” she says.
To help change this scenario, in the last decade, thousands of researchers, pharmaceutical and biotechnology companies, government regulators, payers, clinicians and patients have come together in more than 100 multi-stakeholder collaborations to solve some specific shared problem standing in the way of finding a cure or a better diagnostic approach.
“Multi-stakeholder collaborations provide the opportunity to create an environment that allows for new kinds of interactions among the players,” Hirsch says. The largest multi-stakeholder effort, the European Union’s Innovative Medicines Initiative (IMI) began in 2008 and has established more than 40 consortia with financial and in-kind investments totaling €2 billion. Some projects focus on specific health issues, such as Alzheimer’s disease, chronic pain, diabetes and obesity. Others tackle bigger issues, such as drug and vaccine safety and the use of stem cells for drug discovery. The success has led to a proposal to extend the effort for 10 years and €3.5 billion. Last year, the U.S. President’s Council of Advisors on Science and Technology (PCAST) recommended the U.S. form something similar.
“The prevalence of multi-stakeholder initiatives reflects a continued optimism about the value of this collaboration approach for addressing biomedical innovation bottlenecks,” the authors write in the paper. “Although the need for collaboration is no longer in question, it is worth noting the importance of this development. A willingness to share proprietary data among industry competitors represents a dramatic shift in the culture of the historically highly competitive pharmaceutical industry.”
The article reviews the history of collaborations beginning with HIV/AIDS. By the early 2000s, multi-stakeholder collaborations proliferated to address the need for important tools, such as biomarkers, that require preclinical data sharing. Since then, they have reached to encompass later stages in product development, including manufacturing, reimbursement and post-market monitoring.
Some people involved in multi-stakeholder consortia are concerned about redundancy, inefficiency and lack of productivity of some collaborative efforts, all contributing to a sense of “consortium fatigue,” the researchers write.
In a newer trend, funders and participants are seeking a smaller number of strategically coordinated initiatives that will reliably address critical gaps, Hirsch and Papadaki write. They cite the example of TransCelerate BioPharma, a group of 10 major pharmaceutical companies that came together to share and direct resources toward selected priorities in order to improve the efficiency of drug development, such as clinical trial site qualification standards.
The authors propose a rigorous evidence-based approach (the science of collaboration) to figure out what works and doesn’t work in collaborations. They recommend early steps in this new field and structuring the research to help learn from the past but also to evolve effectively as new innovation challenges emerge.
The Latest on: Science of collaboration
Lighting Science Partners with Six Senses Hotels Resorts Spas
on June 14, 2018 at 10:08 am
WEST WARWICK, R.I.--(BUSINESS WIRE)--Jun 14, 2018--Lighting Science ®, the global pioneer in biological ... share a scientific and holistic approach to wellness, and through this collaboration will offer Six Senses’ guests a better night’s sleep ... […]
Benchmark Leads Funding in Life Science Software Startup
on June 14, 2018 at 8:30 am
Sign in or subscribe for access to peerless insight & analysis, curated data & interactives, and networking events. […]
Kanazawa University: Call for Bio-SPM Collaborative Research Proposals
on June 14, 2018 at 1:31 am
The Nano Life Science Institute (NanoLSI), Institute for Frontier Science Initiative, Kanazawa University, is calling for proposals for Bio-SPMs collaborative research. WPI-NanoLSI, Kanazawa University, aims to contribute to the development of the nano ... […]
Kids discover science, learning is fun at Camp Invention
on June 13, 2018 at 3:56 pm
“Camp Invention opens up the world of science and engineering for young scientists and builds confidence and creativity while teaching STEM concepts. Camp Invention's hands-on activities encourage curiosity and collaboration while children work together ... […]
The Future of Business Transformation Rests in the Hands of This Shift
on June 13, 2018 at 12:55 pm
He went on to graduate with a Master's of Science in Orthotics and Prosthetics and is now collaborating with BASF and Essentium to bring revolutionary 3D-printed sockets to life. This is how collaboration changes lives, and how it is already changing business. […]
Orange Blossom Pilsner gets Inoculated in father, son collaboration
on June 13, 2018 at 10:40 am
“Through my father’s company and his passion for the science of beer, I was able to find out that ... I think that this sort of father’s day collaboration beer is a decent way to show that.” IHOP changing to IHOb does not taste good to a lot ... […]
Indigenous kids content goes from science to superheros
on June 13, 2018 at 8:05 am
We have Indigenous math and science.” In that same vein, Todd is also prepping Fierce Girls, a new tween-skewing transmedia project in collaboration with New Zealand-based Maori news and information site TangataWhenua.com. The 21-webisode co-pro is the ... […]
Life Science Washington’s Inaugural East-West Summit
on June 12, 2018 at 4:50 pm
Floyd College of Medicine Collaboration: An Innovative Approach to Putting Personalized Medicine into Action Impacting Global Public Health through Cross-State Collaborations: The Antimicrobial Resistance Coalition Building Life Science Companies ... […]
International collaboration studies the predictability of earthquakes
on June 12, 2018 at 9:06 am
according to David Rhoades of GNS Science and colleagues. With some caveats, the lessons learned from CSEP experiments can be used to evaluate "classic" forecasts with an eye to making future forecasts more testable. In his focus paper, UCLA emeritus David D. […]
Canopy Growth and Molecular Science Corp. Announce Collaboration to Advance Cannabis Testing Across Canada
on June 7, 2018 at 4:36 am
SMITHS FALLS, ON, June 7, 2018 /CNW/ - Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth" or the "Company") is pleased to announce that it has entered into a collaboration agreement with Canadian laboratory services company Molecular ... […]
via Google News and Bing News